Thomas J Ridge
CIK 1320299 · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.00M
Companies
9
Total Filings
143
Lifetime Open-Market Net
-$908.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYX | Director | 1,068,193 | $1.21 | $1.29M | $0 | 11 | 2026-04-02 |
| HSY | Director | 35,884 | $183.96 | $6.60M | -$30.4K | 67 | 2018-04-03 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Director | — | — | — | $0 | 2 | 2017-11-06 |
| LIFELOCK, INC. (LOCK) Delisted | Director | 38,861 | — | — | -$998.0K | 7 | 2016-05-06 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Director | 24,306 | — | — | $0 | 2 | 2016-03-04 |
| EXC | Director | 19,351 | $45.12 | $873.2K | $0 | 29 | 2014-01-02 |
| BRIGHTPOINT INC (CELL) Delisted | Director | 0 | $1.00 | $0 | $120.0K | 3 | 2012-10-16 |
| VG | Director | 89,441 | $13.73 | $1.23M | $0 | 14 | 2010-04-05 |
| HD | Director | — | $344.56 | — | $0 | 7 | 2007-05-25 |
Recent Filings · Page 10 of 15
143 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-02 | HSY | Grant (A) | +699 | $0 | EDGAR |
| 2010-04-01 | EXC | Grant (A) | +554 | $25.0K | EDGAR |
| 2010-03-15 | HSY | Grant (A) | +541 | $20.0K | EDGAR |
| 2010-01-05 | HSY | Grant (A) | +828 | $30.0K | EDGAR |
| 2010-01-05 | VG | Grant (A) | +7,142 | $0 | EDGAR |
| 2010-01-05 | EXC | Grant (A) | +490 | $25.0K | EDGAR |
| 2009-12-15 | HSY | Grant (A) | +517 | $20.0K | EDGAR |
| 2009-10-05 | VG | Grant (A) | +7,500 | $0 | EDGAR |
| 2009-10-02 | HSY | Grant (A) | +768 | $30.0K | EDGAR |
| 2009-10-01 | EXC | Grant (A) | +514 | $25.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.